129 related articles for article (PubMed ID: 34866182)
1. Childhood aggressive B-cell non-Hodgkin lymphoma in low-middle-income countries.
Moleti ML; Testi AM; Foà R
Br J Haematol; 2022 Feb; 196(4):849-863. PubMed ID: 34866182
[TBL] [Abstract][Full Text] [Related]
2. Optimizing outcomes for children with non-Hodgkin lymphoma in low- and middle-income countries by early correct diagnosis, reducing toxic death and preventing abandonment.
Chantada G; Lam CG; Howard SC
Br J Haematol; 2019 Jun; 185(6):1125-1135. PubMed ID: 30740656
[TBL] [Abstract][Full Text] [Related]
3. Paediatric non-Hodgkin lymphoma in low and middle income countries.
Gross TG; Biondi A
Br J Haematol; 2016 May; 173(4):651-4. PubMed ID: 27098084
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study.
Global Health Research Group on Children’s Non-Communicable Diseases Collaborative
BMJ Open; 2022 Apr; 12(4):e054690. PubMed ID: 35410925
[TBL] [Abstract][Full Text] [Related]
5. The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study.
Anacak Y; Zubizarreta E; Zaghloul M; Laskar S; Alert J; Gondhowiardjo S; Giselvania A; Correa-Villar R; Pedrosa F; Dorj B; Kamer S; Howard SC; Quintana Y; Ribeiro RC; Rosenblatt E; Hopkins K
Clin Oncol (R Coll Radiol); 2021 Apr; 33(4):e211-e220. PubMed ID: 33250288
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.
Perry AM; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD
Haematologica; 2016 Oct; 101(10):1244-1250. PubMed ID: 27354024
[TBL] [Abstract][Full Text] [Related]
7. Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies.
Egan G; Goldman S; Alexander S
Br J Haematol; 2019 Jun; 185(6):1071-1085. PubMed ID: 30613948
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China.
Wang C; Xia B; Ning Q; Zhao H; Yang H; Zhao Z; Wang X; Wang Y; Yu Y; Zhang Y
Ann Hematol; 2018 Mar; 97(3):453-457. PubMed ID: 29188315
[TBL] [Abstract][Full Text] [Related]
9. Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.
Perry AM; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD
Br J Haematol; 2016 Mar; 172(5):699-708. PubMed ID: 26684877
[TBL] [Abstract][Full Text] [Related]
10. Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
Glass S; Phan A; Williams JN; Flowers CR; Koff JL
Discov Med; 2016 Mar; 21(115):181-8. PubMed ID: 27115168
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.
Porcu P; Nichols CR
Curr Probl Cancer; 1998; 22(5):283-368. PubMed ID: 9869020
[TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin lymphoma in Jordan. Types and patterns of 111 cases classified according to the WHO classification of hematological malignancies.
Almasri NM; Habashneh MA; Khalidi HS
Saudi Med J; 2004 May; 25(5):609-14. PubMed ID: 15138528
[TBL] [Abstract][Full Text] [Related]
13. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
14. Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries.
Naresh KN; Advani S; Adde M; Aziz Z; Banavali S; Bhatia K; Belgaumi A; Ezzat A; Khaled H; Mokhtar N; Norton A; Rohatiner A; Sagar TG; Taciyliz N; Temmim L; Venkatesh C; Yan Tang J; Magrath I
Blood Cells Mol Dis; 2004; 33(3):330-7. PubMed ID: 15528153
[TBL] [Abstract][Full Text] [Related]
15. Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science.
Cairo MS; Pinkerton R
Br J Haematol; 2016 May; 173(4):507-30. PubMed ID: 27133800
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
Mann G; Attarbaschi A; Burkhardt B; Niggli F; Klapper W; Ludwig WD; Schrappe M; Zimmermann M; Gadner H; Reiter A;
Br J Haematol; 2007 Nov; 139(3):443-9. PubMed ID: 17868047
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of lymphoma in Bahrain. A retrospective analysis according to the World Health Organization classification.
Aljufairi EA; George SM; Alshaikh SA; Radhi AA; Mohamed RM
Saudi Med J; 2018 Jul; 39(7):736-739. PubMed ID: 29968899
[TBL] [Abstract][Full Text] [Related]
18. Trends in the incidence of Non-Hodgkin's lymphoma in India.
Yeole BB
Asian Pac J Cancer Prev; 2008; 9(3):433-6. PubMed ID: 18990016
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
